12th Edition of International Conference on
Neurology and Neurological Disorders
June 22-24, 2026 | Barcelona, Spain
Neuropharmacology and Novel Drug Development
Neuropharmacology and novel drug development are at the forefront of tackling neurological and psychiatric disorders. This field focuses on understanding the interactions between drugs and the nervous system to design targeted therapies. Advances in receptor biology, neurotransmitter dynamics, and signal transduction pathways are driving innovations in drug discovery. Emerging technologies, such as high-throughput screening and in silico modeling, accelerate the identification of potential therapeutic compounds. Breakthroughs in neuropharmacology also emphasize precision medicine, tailoring treatments to individual genetic and biochemical profiles. These developments hold promise for addressing challenges in managing disorders like schizophrenia, epilepsy, and neurodegeneration effectively.
Ken Ware
NeuroPhysics Therapy, Australia
Robert B Slocum
University of Kentucky HealthCare, United States
Yong Xiao Wang
Albany Medical College, United States
Roger H Coletti
Interventional Health, PA, United States
Sid O Bryant
Texas College of Osteopathic Medicine and University of North Texas Health Science Center Fort Worth, United States
Edie Raether
NeuroShifts and Wings for Wishes Academy, United States
Sergey Victorovich Suchkov
N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian FederationSubmit your abstract Today
Title : Scalp acupuncture with functional electrical stimulation for the treatment children with autism spectrum disorder
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy, Australia
Title : A structure-based strategy to target pathogenic α-synuclein in Parkinson’s disease
Salvador Ventura, Autonomous University of Barcelona, Spain
Title : Rabies: Challenges in taming the beast
Alan C Jackson, University of Calgary, Canada
Title : Designing and managing intelligent and ethical transformed health and social care ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Understanding Alzheimer's disease biomarkers across diverse populations - Opportunities and Insights for novel prevision medicine approaches
Sid O Bryant, Texas College of Osteopathic Medicine and University of North Texas Health Science Center Fort Worth, United States